Papers by Mei Hu
2 results
- ADA Scientific Sessions 2025 Abstract
Targeting Activin Type II Receptors—Develop Monoclonal Antibodies LAE102, LAE103, and LAE123 as Candidate Therapeutics for Muscle Growth and Fat Reduction
Experiments in animalsInterventions